Microbix Biosystems Statistics

Total Valuation

Microbix Biosystems has a market cap or net worth of 43.97 million. The enterprise value is 37.82 million.

Market Cap	43.97M
Enterprise Value	37.82M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Microbix Biosystems has 136.92 million shares outstanding. The number of shares has decreased by -5.12% in one year.

Shares Outstanding	136.92M
Shares Change (YoY)	-5.12%
Shares Change (QoQ)	+1.11%
Owned by Insiders (%)	14.35%
Owned by Institutions (%)	0.42%
Float	115.60M

Valuation Ratios

The trailing PE ratio is 10.67 and the forward PE ratio is 17.76.

PE Ratio	10.67
Forward PE	17.76
PS Ratio	1.84
Forward PS	n/a
PB Ratio	1.58
P/FCF Ratio	23.82
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.20, with an EV/FCF ratio of 20.49.

EV / Earnings	9.31
EV / Sales	1.59
EV / EBITDA	6.20
EV / EBIT	8.05
EV / FCF	20.49

Financial Position

The company has a current ratio of 6.64, with a Debt / Equity ratio of 0.24.

Current Ratio	6.64
Quick Ratio	4.66
Debt / Equity	0.24
Debt / EBITDA	1.10
Debt / FCF	3.64
Interest Coverage	12.08

Financial Efficiency

Return on equity (ROE) is 14.63% and return on invested capital (ROIC) is 13.63%.

Return on Equity (ROE)	14.63%
Return on Assets (ROA)	10.71%
Return on Capital (ROIC)	13.63%
Revenue Per Employee	238,352
Profits Per Employee	40,613
Employee Count	100
Asset Turnover	0.66
Inventory Turnover	2.83

Taxes

Income Tax	-5
Effective Tax Rate	-0.00%

Stock Price Statistics

The stock price has decreased by -20.00% in the last 52 weeks. The beta is 0.25, so Microbix Biosystems's price volatility has been lower than the market average.

Beta (1Y)	0.25
52-Week Price Change	-20.00%
50-Day Moving Average	0.35
200-Day Moving Average	0.34
Relative Strength Index (RSI)	41.05
Average Volume (30 Days)	62,536

Short Selling Information

The latest short interest is 29,536, so 0.02% of the outstanding shares have been sold short.

Short Interest	29,536
Short Previous Month	2,184
Short % of Shares Out	0.02%
Short % of Float	0.03%
Short Ratio (days to cover)	0.62

Income Statement

In the last 12 months, Microbix Biosystems had revenue of 23.84 million and earned 4.06 million in profits. Earnings per share was 0.03.

Revenue	23.84M
Gross Profit	12.96M
Operating Income	4.70M
Pretax Income	4.06M
Net Income	4.06M
EBITDA	6.10M
EBIT	4.70M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 12.87 million in cash and 6.72 million in debt, giving a net cash position of 6.16 million or 0.04 per share.

Cash & Cash Equivalents	12.87M
Total Debt	6.72M
Net Cash	6.16M
Net Cash Per Share	0.04
Equity / Book Value	27.76M
Book Value Per Share	0.20
Working Capital	20.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.85 million and capital expenditures -1.01 million, giving a free cash flow of 1.85 million.

Operating Cash Flow	2.85M
Capital Expenditures	-1.01M
Free Cash Flow	1.85M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 54.38%, with operating and profit margins of 19.72% and 17.04%.

Gross Margin	54.38%
Operating Margin	19.72%
Pretax Margin	17.04%
Profit Margin	17.04%
EBITDA Margin	25.59%
EBIT Margin	19.72%
FCF Margin	7.74%

Dividends & Yields

Microbix Biosystems does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	5.12%
Shareholder Yield	5.12%
Earnings Yield	9.24%
FCF Yield	4.20%

Analyst Forecast

Price Target	0.80
Price Target Difference	150.00%
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a